More about the webinar

© 2016 marcus evans webinars

Our panel of speakers

Dr David Hallett has more than 20 years drug discovery expertise.  He joined Evotec in September 2005 and from 2009-2015 was Executive Vice President of Chemistry where he had operational responsibility for its chemistry, computational chemistry and DMPK groups.   Since 2015 he has constructed and is now leading an Alliance Management function within Evotec.  Prior to joining Evotec, he was a Research Fellow at Merck Sharp & Dohme for 10 years where he led a number of successful drug discovery teams, mainly in the area of psychiatry.

 

Dr David Hallett
EVP Alliance Management
Evotec
 
Download Webinar Material

Complimentary Webinar

The Sanofi – Evotec Alliance

A revealing case study showcasing a winning partnership

in partnership with

Strategic alliances are key  for sustaining high levels of  scientific and technological activities, improving drug discovery and pre-clinical development effectiveness and accelerating pipeline productivity. In 2015, Sanofi and Evotec signed an agreement for a major multi-component strategic alliance.  This alliance is intended to provide both services and innovation to Sanofi and involved Evotec integrating a state-of-the-art Sanofi facility and more than 200 highly qualified and experienced employees in Toulouse, France.  This webinar reflects on the past 18 months describing the major components of the agreement, how they were “operationalized” and the benefits to both parties.

Dominique Sonneville has almost 20 years’ experience in the pharmaceutical industry. Dominique joined Sanofi in January 1998. Throughout her career she has occupied various operational functions initially within strategic marketing on both a country and European-wide level. In 2011 she moved to an Alliance Management function within R&D covering alliances with major pharmaceutical companies, biotech’s and academic institutions. Since April 2015 she has been responsible for the partnership with Evotec. 

Dominique Sonneville
Alliance Manager R&D
Sanofi
 
During this complimentary hour, our speakers discuss:
 

The situation in both companies before the partnership

Deal Structure

The key partnership components in place ensuring capacity and capability expansion, research platform reinforcement  and optimized communication

The proven benefits for both parties after 18 months of partnership